CHARACTERIZATION OF THE DISCOIDIN DOMAIN RECEPTOR 2 KINASE AS A NOVEL THERAPEUTIC TARGET FOR SQUAMOUS CELL LUNG CANCER

$214,656FY2010Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators